600 patients66,869 observations120 daysLIVE

Patient P-01679

Synthetic patientNBL-101 · Day 113 · 35–44 · F · baseline S12Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Improving
Discontinuation risk
22%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S12
  2. Day 72 AD-05 recommendedAdherence Support AD-05
  3. Day 73 Patient acceptedStarted AD-05 in the companion
  4. Day 78 No meaningful changeAdherence Support AD-05
  5. Day 86 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 86.

Primary contributors, last 14 days
  • Inflammatory activity+9
  • Treatment adherence-7
  • GI instability-4
  • Nutritional resilience+4

What helped?

  • Adherence Support AD-05Day 72
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
20/100
worsening · +2.8 vs previous 14 d
Toxicity
Blood
27.1/100
worsening · +2.7 vs previous 14 d
Sleep quality
Wearable
44.7/100
stable · +0.6 vs previous 14 d
Energy level
Daily log
5.7/10
worsening · -0.3 vs previous 14 d
Stress level
Daily log
3.7/10
worsening · +0.3 vs previous 14 d
Steps
Wearable
9,855
stable · -257 vs previous 14 d
Adherence
Companion
77.8 %
stable · -3.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 61 from the failing basin, 41 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
Would not help
  • AD-05 Adherence Support
    already tried, no meaningful change
  • Keep alcohol low
    GI +4.1 next day on high-intake days · n 20
  • Keep spicy low
    GI +2.8 next day on high-intake days · n 21
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Alcohol
    +4.1detractor · 95%
  • Spicy / capsaicin
    +2.8detractor · 88%
  • Insoluble fibre
    -0.7no signal · 15%
  • Histamine load
    -0.3no signal · 15%
  • Dietary fat load
    -0.1no signal · 15%
  • Simple carbohydrates
    0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 25
    • DNAIL6 -174 variant raises baseline inflammatory tone
  • Autonomic recovery 20
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Rapid metabolizer
    Expected exposure
Microbiome
Shannon diversity 3.4 · butyrate capacity 47/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
57 ms
Sleep
6.5 h
Steps
9,123
Resting HR
58 bpm
Daily log: GI score 20, nutritional resilience 65, adherence 78.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0135049%S19BR-03no change34
P-0134546%S1230
P-0172246%S0936
P-0184645%S0137
P-0137743%S11AD-05no change42
P-0148342%S14AD-05no change35
P-0184841%S05AD-05no change23
P-0181640%S0135
P-0182940%S1131
P-0188240%S1844
P-0137039%S0344
P-0140139%S1534